The PERK- and ATF6-mediated pathways have also been widely implicated in HCC progression by increasing HCC chemoresistance and promoting tumor invasiveness and adaptation to hostile microenvironmental conditions [7,8]. Here, EIF2AK3 is linked to hepatocellular carcinoma.